Health ❯Healthcare

Pharmaceuticals

Pharmaceuticals Healthcare Policy Health Policy Drug Pricing Healthcare Policy Clinical Trials Medical Research Public Health Regulatory Affairs Drug Manufacturers

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

The company plans to resubmit its application later this year following interim results from its Phase 3 flu vaccine trial, expected this summer.

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Noom Introduces Personalized Microdoses of Compounded Wegovy Ahead of FDA Deadline

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies

FDA Approves First Blood Test for Alzheimer’s Diagnosis

Trump Expands Drug Pricing Model to Medicare and Medicaid, Targets Global Parity

HHS Orders FDA Review of Abortion Pill Following Controversial Analysis

FDA Audit Triggers Nationwide Recall of Over 75,000 Eye Care Products

Trump’s Executive Order Targets Prescription Drug Prices and PBMs

Oxford Study Reveals Rapid Weight Regain After Stopping GLP-1 Drugs

SYNT-101 Shows Promise in Early Human Trials as a Non-Invasive Obesity Treatment

Trump's Executive Order Targets U.S. Drug Price Disparities

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

Trump’s Executive Order Targets U.S. Drug Prices with Foreign Rate Parity

Nationwide Recall of Eye Care Products Over Sterility Concerns

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial

Newsom Pushes State Regulation of PBMs and CalRx Expansion in 2025 Budget Plan

Breast Cancer Trial Achieves 100% Survival with Pre-Surgery Olaparib

Trump Signs Sweeping Order to Cap U.S. Drug Prices at Global Lows

NHS Expands Use of Smart Scales to Address Severe Childhood Obesity